Imaging leadership Guerbet is a global leader in medical imaging with a broad portfolio of pharmaceutical products, medical devices, and AI-driven diagnostic and interventional imaging solutions, signaling substantial upsell potential across imaging centers and hospitals seeking integrated imaging workflows.

R&D investment With approximately 9% of revenue invested in R&D and dedicated innovation centers in France and the United States, Guerbet demonstrates a strong emphasis on advanced imaging technologies, creating opportunities for collaborative pilots, early access programs, and co-development partnerships.

Sustainability base Adherence to ISO 14001 and a tech stack including cloud and enterprise platforms indicate mature operations and potential alignment with sustainability-focused procurement programs, appealing to hospitals and health systems prioritizing environmental responsibility.

Scale and reach Employee base and revenue positioning (over 1,000 employees with multi-billion revenue potential) suggest capability to support large-scale deployments, enterprise agreements, and training partnerships across cardiology, radiology, and interventional specialties.

Digital ecosystem Existing technologies such as Kubernetes, Salesforce, SAP Concur, Microsoft 365 tools, and AI-driven imaging solutions position Guerbet for cross-sell of integrated software, managed services, and data-driven capabilities to optimize imaging workflows.